Emgality Receives First FDA Approval for Treating Cluster Headache
Patients treated with Emgality had 8.7 fewer cluster headache attacks at 3.0 weeks versus 5.2 with placebo
App Helps Pediatric Asthma Patients, Parents Self-Monitor
With one year of use, improvements seen in asthma outcomes
No Evidence of Legacy Effect Seen for Intensive Glucose Lowering
Findings based on 15-year follow-up study conducted among veterans with type 2 diabetes
Lowering Cholesterol Levels May Worsen Nerve Damage in T2DM
Higher number of nerve lesions, declining nerve conduction velocities and amplitudes seen
Workplace Exposures Contribute to Burden of Respiratory Disease
Substantial contribution seen to burden of diseases including asthma, COPD, chronic bronchitis, fibrosis
Carotid Atherosclerosis Predicts CV Events in Psoriatic Disease
After controlling for Framingham Risk Score, TPA, mean and max cIMT predict incident CVEs
Immunizations Up in California After Repeal of Nonmedical Exemptions
At the same time, there was a sharp increase in medical exemptions in a few California counties
Nonsuicidal Self-Injury Rate Up in Sexual-Minority Youth
Prevalence of NSSI ranged from 38.04 to 52.97 percent for sexual-minority youth between 2005 and 2017
Staphylococcus aureus Linked to Food Sensitization in Eczema
Children with S. aureus more likely to have persistent egg, peanut allergy independent of eczema severity
May 2019 Briefing – Family Practice
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for May 2019. This roundup includes the...
